Effects of oral nicotine pouches on cigarette smoking behaviour and tobacco harm exposure: a randomised pilot trial in adults
- 23 June 2025
- journal article
- Published by BMJ in Tobacco Control
Abstract
Oral nicotine pouches may have potential for smoking cessation, but scientific evidence on the effects of pouches and their constituents on smoking behaviour is limited.Design: This study was a 4-week, open-label, randomised pilot trial of nicotine pouches in 3 mg (low) or 6 mg (high) nicotine strength.Subjects: US outpatient research clinic with non-treatment seeking adults who smoke cigarettes (N=30).Interventions: Participants selected two flavours and were instructed to switch to using nicotine pouches in place of cigarettes.Main outcome measures: We compared groups on cigarettes smoked per day, pouch use and urinary levels of a tobacco-specific carcinogen (NNAL) over 4 weeks, biochemically verified 7-day point prevalence smoking abstinence at week 4, and willingness to continue pouch use.Results: Nearly all participants completed the trial (29/30). Participants in both groups significantly reduced their cigarettes smoked per day (log-transformed) over time (F3, 74.4=3.8, p=0.01). The 6 mg group reported numerically greater, but non-significant, reductions in smoking than the 3 mg group (least-square mean difference (LSMD) at week 1=0.008; 95% CI −0.42–0.44; LSMD at week 4=0.38; 95% CI −0.06–0.81). The 6 mg group also reported numerically higher, but non-significant, likelihood of complete smoking abstinence (13% vs 0%) and willingness to continue pouch use (67% vs 40%). There were no differences by group or time for NNAL.Conclusions: Results provide preliminary support for nicotine pouches for cigarette substitution. Compared with lower nicotine strength pouches, higher nicotine strength pouches may have a greater impact on smoking behaviour and adults who smoke may be more willing to use them.Trial registration number: NCT04250727.Keywords
Funding Information
- Center for Tobacco Products (U54DA036151)
- National Institute on Drug Abuse (K23DA045957)
This publication has 27 references indexed in Scilit:
- Nicotine pharmacokinetics and subjective responses after using nicotine pouches with different nicotine levels compared to combustible cigarettes and moist smokeless tobacco in adult tobacco usersPsychopharmacology, 2022
- A randomised, open-label, cross-over clinical study to evaluate the pharmacokinetic, pharmacodynamic and safety and tolerability profiles of tobacco-free oral nicotine pouches relative to cigarettesPsychopharmacology, 2022
- A Randomised Study to Investigate the Nicotine Pharmacokinetics of Oral Nicotine Pouches and a Combustible CigaretteEuropean Journal of Drug Metabolism and Pharmacokinetics, 2021
- Nicotine pharmacokinetics and subjective response among adult smokers using different flavors of on!® nicotine pouches compared to combustible cigarettesPsychopharmacology, 2021
- Nicotine Pouch Unit Sales in the US, 2016-2020JAMA, 2021
- Validation of a multisubstance online Timeline Followback assessmentBrain and Behavior, 2019
- Reliability of the Timeline Followback for cocaine, cannabis, and cigarette use.Psychology of Addictive Behaviors, 2014
- Applying Tobacco Carcinogen and Toxicant Biomarkers in Product Regulation and Cancer PreventionChemical Research in Toxicology, 2010
- Validity of the timeline followback among treatment-seeking smokers in GermanyDrug and Alcohol Dependence, 2009
- Reliability and validity of a smoking timeline follow-back interview.Psychology of Addictive Behaviors, 1998